Tomo, Jameson O.

HRN: 19-89-12  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/16/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/16/2023
10/22/2023
IV
220mg
Q6
Pcap C
Waiting Final Action 
10/21/2023
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
10/21/2023
10/28/2023
PO
2.5ml
BID
PCAP
Waiting Final Action 
10/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/23/2023
10/29/2023
IVT
45mg
Q8
Sepsis
Waiting Final Action 
10/23/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/23/2023
10/29/2023
IVT
650mg
Q6
Sepsis
Waiting Final Action 
10/23/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
10/23/2023
11/18/2023
IVT
650mg
Q6
Sepsis
Waiting Final Action 
10/31/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
10/31/2023
11/14/2023
IVT
50mg
OD
PCAP C
Waiting Final Action 
11/01/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/01/2023
11/07/2023
IV
90mg
Q8
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: